Status:
COMPLETED
Early Diabetes Resolution After Weight Loss Surgery
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Obesity
Diabetes
Eligibility:
All Genders
18-65 years
Brief Summary
The primary objective is to compare inflammatory, hormonal, and metabolic changes in the very short term after various bariatric surgical procedures (Roux-en Y Gastric Bypass, Vertical Sleeve Gastrect...
Eligibility Criteria
Inclusion
- Inclusion Criteria for surgery groups:
- BMI of 30 kg/m2 or higher
- Ages 18-65
- History of impaired glucose tolerance or T2DM
- Inclusion Criteria for normal weight group:
- BMI of 30 kg/m2 or lower
- Ages 18-65
- Exclusion Criteria:
- Development of an intercurrent infection
- Prior gastric, duodenal, proximal jejunal surgery or pancreas resection
- Current use of thiazolidinediones
- Current use of dipeptidyl peptidase-IV inhibitors (e.g., sitagliptin) or glucagon-like peptide-1 analogs (e.g., exenatide)
- Any condition felt by the PI or co-investigators to interfere with ability to complete the study
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00790309
Start Date
December 1 2008
End Date
February 1 2017
Last Update
April 21 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.